S-8 1 forms-8081225.htm S-8 Document

As filed with the Securities and Exchange Commission on August 12, 2025.
Registration No. 333-

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
                                                                                             

FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                                                                             

VIEMED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
                                                                                                 
British Columbia, CanadaN/A
(State or Other Jurisdiction
of Incorporation or Organization)
(I.R.S. Employer
Identification No.)
625 E. Kaliste Saloom Rd.
Lafayette, Louisiana 70508
(Address of Principal Executive Offices) (Zip Code)
                                                                                             
VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN
(Full Title of the Plan)

Name, Address and TelephoneCopy of Communications to:
Number of Agent for Service:
Trae FitzgeraldE. James Cowen
Chief Financial OfficerPorter Hedges LLP
Viemed Healthcare, Inc.
1000 Main Street, 36th Floor
625 E. Kaliste Saloom Rd.Houston, Texas 77002-6336
Lafayette, Louisiana 70508(713) 226-6000
(337) 504-3802
                                                                                                 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer (Do not check if a smaller reporting company)
Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.






___________________________

EXPLANATORY NOTE

This Registration Statement on Form S-8 is filed by Viemed Healthcare, Inc. (the “Company”) to register an additional 412,351 common shares of the Company (the “Common Shares”) for issuance pursuant to the Viemed Healthcare, Inc. 2024 Long Term Incentive Plan, as amended (the “2024 Plan”). The 2024 Plan was described in the Company’s definitive Proxy Statement for its 2025 Annual Meeting of Shareholders held on June 5, 2025. An amendment to the 2024 Plan to add an additional 412,351 Common Shares to the 2024 Plan was approved by the Company’s shareholders at that meeting.

The 412,351 Common Shares being registered hereby are in addition to the Common Shares registered by the Company’s prior Registration Statement on Form S-8 (the “Prior Registration Statement”) filed on August 12, 2024 (File No. 333-281502). Pursuant to General Instruction E of Form S-8, the contents of the Prior Registration Statement are incorporated by reference herein except as otherwise amended or superseded hereby. Upon the effectiveness of this Registration Statement, the total number of Common Shares registered for issuance under the 2024 Plan will correspond to the aggregate 7,904,757 Common Shares available for issuance as of the date of the amendment to the Plan.


Item 8. Exhibits.

See Index to Exhibits, attached hereto, which Index to Exhibits is hereby incorporated into this Item 8.



SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Lafayette, State of Louisiana, on this 12th  day of August, 2025.
VIEMED HEALTHCARE, INC.
By:/s/ Trae Fitzgerald
Trae Fitzgerald
Chief Financial Officer

POWER OF ATTORNEY

    KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Casey Hoyt, W. Todd Zehnder and Trae Fitzgerald, and each of them, either of whom may act without joinder of the other, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any or all pre- and post-effective amendments and supplements to this registration statement, and to file the same, or cause to be filed the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and each of them, or the substitute or substitutes of either of them, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
SignatureTitleDate
/s/ Casey HoytChief Executive Officer and DirectorAugust 12, 2025
Casey Hoyt(Principal Executive Officer)
/s/ Trae FitzgeraldChief Financial OfficerAugust 12, 2025
Trae Fitzgerald(Principal Financial Officer and Accounting Officer)
/s/ W. Todd ZehnderChief Operating Officer and DirectorAugust 12, 2025
W. Todd Zehnder
/s/ Randy DobbsChairman of the BoardAugust 12, 2025
Randy Dobbs
/s/ Dr. William FrazierDirector and Chief Medical OfficerAugust 12, 2025
Dr. William Frazier
/s/ Sabrina HeltzDirectorAugust 12, 2025
Sabrina Heltz
/s/ Nitin KaushalDirectorAugust 12, 2025
Nitin Kaushal
/s/ Timothy SmokoffDirectorAugust 12, 2025
Timothy Smokoff




INDEX TO EXHIBITS